Anzeige
Mehr »
Dienstag, 10.02.2026 - Börsentäglich über 12.000 News
Breaking News: Pacifica meldet neue hochgradige Entdeckung und genau deshalb kann der Markt das nicht ignorieren
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
32 Leser
Artikel bewerten:
(0)

Most Online Tests For Alzheimer's Disease Fail On Scientific Validity, Reliability And Ethical Factors

BOSTON, July 15, 2013 /PRNewswire-USNewswire/ -- An expert panel found that 16 freely accessible online tests for Alzheimer's disease scored poorly on scales of overall scientific validity, reliability and ethical factors, according to new data reported today at the Alzheimer's Association International Conference® 2013 (AAIC® 2013) in Boston.

"As many as 80 percent of Internet users, including a growing proportion of older adults, seek health information and diagnoses online," said Julie Robillard, Ph.D., a postdoctoral fellow at the National Core for Neuroethics at the University of British Columbia in Vancouver, British Columbia, Canada, who presented the data at AAIC 2013.

"Self-diagnosis behavior in particular is increasingly popular online, and freely accessible quizzes that call themselves 'tests' for Alzheimer's are available on the Internet. However, little is known about the scientific validity and reliability of these offerings and ethics-related factors including research and commercial conflict of interest, confidentiality and consent. Frankly, what we found online was distressing and potentially harmful," Robillard added.

According to the Alzheimer's Association 2013 Alzheimer's Disease Facts and Figures report, more than 5 million Americans are living with Alzheimer's disease. By 2050, the number of people with Alzheimer's could reach 13.8 million. Other estimates suggest that number could be high as 16 million.

"The number of people with Alzheimer's is projected to rise significantly as more and more people age into greater risk for developing the disease," said Maria Carrillo, Ph.D., Alzheimer's Association vice president of medical and scientific Relations. "Especially in that context, active promotion of healthy aging is a priority for the Alzheimer's Association, as is the delivery of accurate, reliable and ethical information and services."

Alzheimer's disease is the sixth-leading cause of death in the United States and is the only leading cause of death without a way to prevent, cure or even slow its progression.

Robillard and colleagues at the University of British Columbia used information-mining techniques to retrieve 16 online tests for Alzheimer disease. Unique monthly visitors for the parent sites hosting the online tests ranged from 800 to 8.8 million.

A panel of experts including geriatricians, human-computer interaction specialists, neuropsychologists and neuroethicists reviewed the tests, specifically evaluating the scientific validity and reliability of the assessments, their human-computer interaction features and ethics-related factors. The tests were evaluated on a scale from 1 (very poor) to 10 (excellent).

The researchers found that most of the tests (12 of 16) scored "poor" or "very poor" for overall scientific validity and reliability. These tests "are not useful for the diagnosis of Alzheimer's disease," Robillard said.

All 16 tests scored "poor" or "very poor" on the evaluation criteria for ethical factors. According to Robillard, ethical issues with the tests included overly dense or absent confidentiality and privacy policies, failure to disclose commercial conflicts of interests, failure to meet the stated scope of the test and failure to word the test outcomes in an appropriate and ethical manner.

The majority of tests (10 of the 16) scored "fair" for appropriateness of human-computer interface for an older adult population. According to the researchers, this suggests that the visual aspects of the tests and the motor tasks required would be suitable for older users.

"Freely accessible diagnostic tests that lack scientific validity and conform poorly to guidelines around consent, conflict of interest and other ethical considerations have the potential to harm a vulnerable population and negatively impact their health," Robillard said. "Further evidence and informed policy are needed to promote the greatest benefits from tools and information available on the Internet."

Some examples of evaluation criteria used by the expert panel were:

  • For validity and reliability:
  • Are the content and breadth appropriate to achieve test claims?
  • Are test questions based on current, peer-reviewed evidence?
  • Would the test have test-retest reliability?
  • For user interface:
  • Are the instructions clear and easy to understand?
  • Is the test visually adequate (font size, contrast, etc.)?
  • Does the test take varying levels of computer knowledge into consideration?
  • For ethics:
  • Are issues of privacy and data collection discussed?
  • Are conflicts of interests clearly stated?
  • Is the wording of the outcomes ethically appropriate?

About AAIC
The Alzheimer's Association International Conference (AAIC) is the world's largest conference of its kind. AAIC brings together researchers from around the world to report and discuss groundbreaking research and issues surrounding the cause, diagnosis, treatment and prevention of Alzheimer's disease and related disorders. As a part of the Alzheimer's Association's research program, AAIC serves as a catalyst for generating new knowledge about dementia and fostering a vital, collegial research community.

About the Alzheimer's Association
The Alzheimer's Association is the world's leading voluntary health organization in Alzheimer's disease care, support and research. Our mission is to eliminate Alzheimer's through the advancement of research; provide and enhance care and support for all affected; and reduce the risk of dementia through the promotion of brain health. Our vision is a world without Alzheimer's. Visit www.alz.org or call 800.272.3900.

SOURCE Alzheimer's Association

© 2013 PR Newswire
Favoritenwechsel
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.